[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569390":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":27,"locations":33,"responsibleParty":58,"collaborators":60,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":10,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":82,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":10,"studyType":88,"phases":10,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"University of Colorado, Denver","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients",null,"556 eligible patients will be recruited across 5 participating sites to complete a discrete choice-based conjoint survey. The survey will be distributed to eligible patients via Sawtooth internet survey at the time of a clinic appointment or remotely via video chat.",[13],"Behavioral: Patient survey",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"BEHAVIORAL","Patient survey","To assess patient preferences and barriers for attributes of BE\u002FEAC screening modalities patients will complete a survey evaluating 5 domains: benefit of detection (sensitivity), convenience (time, setting), screening related physical harms (procedural discomfort), and financial harms. Prior to distribution, the survey will be refined and pretested among a sample of 5 patients.",[9],[21,24],{"name":22,"affiliation":5,"role":23},"Sachin Wani, MD","PRINCIPAL_INVESTIGATOR",{"name":25,"affiliation":26,"role":23},"Jennifer Kolb, MD, MS","University of California, Los Angeles",[28],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Alexa DeBord, MS","CONTACT","303-724-0432","alexa.debord@cuanschutz.edu",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"University of Colorado Anschutz Medical Campus","RECRUITING","Aurora","Colorado","80045","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-104.83192,39.72943,{"lat":46,"lon":45},[49,50,51,54,56],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},{"name":22,"role":23,"phone":10,"phoneExt":10,"email":10},{"name":52,"role":53,"phone":10,"phoneExt":10,"email":10},"Sridevi Pokala, MD","SUB_INVESTIGATOR",{"name":55,"role":53,"phone":10,"phoneExt":10,"email":10},"Mohammad Bilal, MD",{"name":57,"role":53,"phone":10,"phoneExt":10,"email":10},"Mark Earnest, MD",{"type":59,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[61,63,64,66,69,72],{"name":62,"class":6},"American Society for Gastrointestinal Endoscopy",{"name":26,"class":6},{"name":65,"class":6},"University of Michigan",{"name":67,"class":68},"Exact Sciences Corporation","INDUSTRY",{"name":70,"class":71},"VA Medical Center-West Los Angeles","FED",{"name":73,"class":6},"University of Texas Southwestern Medical Center","100569390","patient-preferences-for-barretts-esophagus-and-esophageal-cancer-screening-tests-100569390",false,"NCT06693622","Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests","Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests: A Discrete Choice-Based Conjoint Analysis","Inclusion Criteria:\n\n* Provision to sign and date the consent form.\n* Stated willingness to comply with all study procedures and be available for the duration of the study.\n* Individual has 3 or more established risk factors for BE (age \\> 50 years, chronic GERD, male, white race, smoking, obesity, family history of BE\u002FEAC).\n\nExclusion Criteria:\n\n* Unable to consent.\n* Prior diagnosis of BE\u002FEAC.\n* Life limiting comorbidity\u002F disability.\n* Active dementia\u002F cognitive impairment.\n* Incarcerated.",true,"ALL","18 Years","89 Years",{"count":86,"type":87},556,"ESTIMATED","OBSERVATIONAL","This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.",[91,92],"Gastro Esophageal Reflux Disease","Barrett Esophagus",[94,95,96,97,98],"Gastroesophageal Reflux Disease","Barrett's Esophagus","Barrett's Esophagus Screening","BE","GERD","2024-11-14",{"date":101,"type":102},"2024-11-18","ACTUAL",{"date":104,"type":102},"2024-11-01",{"date":106,"type":87},"2029-03-01",{"name":5,"class":6},1]